📰 Genoscience Pharma News
Genoscience Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genoscience Pharma. Real-time updates on events, politics, business and more.
March 24, 2024
Genfit (NASDAQ:GNFT – Get Free Report) and Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends. Institutional & Insider Ownership 8.8% of Genfit shares are […]
March 24, 2024
Genfit (NASDAQ:GNFT – Get Free Report) and Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, valuation and risk. Volatility and Risk Genfit has a beta of 1.08, […]
March 12, 2024
Genfit (NASDAQ:GNFT – Get Free Report) and Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, earnings, institutional ownership, risk, analyst recommendations and valuation. Profitability This table compares Genfit and Sorrento Therapeutics’ […]
February 19, 2024
Genfit (OTCMKTS:GNFTF – Get Free Report) and VBI Vaccines (NASDAQ:VBIV – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Earnings & Valuation This table compares Genfit and VBI […]
January 4, 2024
Genfit (NASDAQ:GNFT – Get Free Report) and Curis (NASDAQ:CRIS – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, analyst recommendations, valuation and institutional ownership. Valuation & Earnings This table compares Genfit and Curis’ […]
January 4, 2024
Bio-Techne (NASDAQ:TECH – Get Free Report) and Genfit (NASDAQ:GNFT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Analyst Ratings This is a summary of current ratings and […]
October 18, 2023
/PRNewswire/ -- DelveInsights Cholangiocarcinoma Market Insights report includes a comprehensive understanding of current treatment practices,...
September 20, 2023
/PRNewswire/ -- DelveInsights Intrahepatic Cholangiocarcinoma Market Insights report includes a comprehensive understanding of current treatment practices,...
September 12, 2023
Genfit (NASDAQ:GNFT – Get Free Report) and Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends and profitability. Analyst Ratings This is a breakdown of […]
September 10, 2023
Genfit (NASDAQ:GNFT – Get Free Report) and Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership. Profitability This table compares Genfit and Monte […]